Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1-6, 8-9, 11, 13-15, 17-18, 20-21, 23, 25, 27-28 and 31 are pending in this application.
Claim Rejections - 35 USC § 112
The following is a quotation of 35 U.S.C. 112(b):
(b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.
The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph:
The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention.
Claims 1-6, 8-9, 11, 13-15, 17-18, 20-21, 23, 25, 27-28 and 31 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1, 13 and 25 and claims dependent thereon are rejected because the phrase “organometallic reagent” is not clear. What is covered and what is not? How can one tell if a given organometallic reagent is not embraced by the claims? It is recited in said claims “reacting an organometallic reagent prepared from a compound of Formula (I)”, but it is unclear what organometallic is reacted to prepare a compound of Formula (I). There is no support in the specification to guide one skilled in the art on how to carry out the reaction using the organometallic reagent. At page 9 of the specification, there is mention of adding copper salt to the reaction mixture but it is unclear how the copper salt is part of the reaction. Scheme 1 at page 28 shows the reaction mechanism, but there is no presence of an organometallic metal or reagent in said Scheme of step 1 or step 2. It is recommended that applicants delete “organometallic reagent” or explain clearly what organometallic reagent is and explain its role in the synthetic process.
Information Disclosure Statement
4. Applicant’s Information Disclosure Statement, filed on 11/24/2025 and 08/01/2025 has been acknowledged. Please refer to Applicant’s copies of the 1449 submitted herewith.
Conclusion
5. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Kahsay Habte Ph.D. whose telephone number is (571)272-0667. The examiner can normally be reached on 8:30 - 5:00 PM.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JEFFREY MURRAY can be reached on 571-272-9023. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see https://ppair-my.uspto.gov/pair/PrivatePair. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/Kahsay Habte/
Primary Examiner, Art Unit 1624